IP Library Granted Patent US 9,090,033
Granted Patent B2
US 9,090,033 · App. 14/094,995 · Granted Jul 28, 2015

Presbyopia-correcting IOL using curvature change of an air chamber

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,090,033
App. No.
14/094,995
Granted
Jul 28, 2015
Kind
B2
Abstract

An accommodative intraocular lens (IOL) system is disclosed for insertion into an eye to provide accommodative vision, the system including a deformable air chamber filled with a transparent, low refractive index medium disposed between the first and second optics; and at least one haptic connected to the air chamber and configured to facilitate a change in the curvature of at least one surface of the chamber, such that when the lens system is positioned in an eye, cilliary muscle movements can alter the curvature of the air chamber and vary the overall lens power of the system.

Claims (14)

1. An accommodative intraocular lens (IOL) system for insertion into an eye to provide accommodative vision, the system comprising:

a flexible shell having an anterior concave surface and a posterior concave surface defining a deformable air chamber;

a transparent, low refractive index medium disposed within the shell, wherein the transparent medium has an index of refraction less than 1.2; and

at least one ring-shaped haptic connected to the shell, the at least one haptic comprising a plurality of spaced-apart and distinct arcuate sections such that the flexible shell is only partially surrounded, each arcuate section connecting to at the anterior surface of the flexible shell at a first anterior portion of the respective arcuate section and at the posterior surface of the flexible shell at a second posterior portion of the respective arcuate section spaced apart from the first portion and configured to facilitate changes in the shape of the air chamber when the haptic is flattened by axially moving the first portion toward the second portion, such that when the lens system is positioned in an eye, ciliary muscle movements can alter the curvature of the anterior and posterior surfaces and vary the overall lens power of the system,

wherein the transparent medium comprises a gas,

wherein each of the anterior concave surface and posterior concave surface has a radius of curvature, and wherein flattening of the haptic causes an increase in both radii of curvature,

wherein the air chamber is configured to form a convergent lens for light entering the anterior surface and exiting the posterior surface when disposed within an aqueous environment, and wherein flattening of the haptic reduces the overall converging power of the convergent lens.

2. The lens system of claim 1 , wherein the transparent medium has an index of refraction less than 1.1.

3. The lens system of claim 1 , wherein the transparent medium comprises air.

4. The lens system of claim 1 , wherein the transparent medium comprises argon.

5. The lens system of claim 1 , wherein the transparent medium comprises at least 90 percent argon.

6. The lens system of claim 1 , wherein a range of haptic displacement provides an accommodation of at least 3 diopters in an aqueous environment by deformation of the flexible shell.

7. The lens system of claim 1 , wherein a range of haptic displacement provides an accommodation of at least 4 diopters in an aqueous environment by deformation of the flexible shell.

8. The lens system of claim 1 wherein the overall optic power of the system is at least 18 Diopters for light entering the anterior surface and exiting the posterior surface when disposed within an aqueous environment.

Assignments (2)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2013
From: CARSON, DANIEL R.; LEE, SHINWOOK
To: NOVARTIS AG
Reel/Frame 031704/0154 →